Literature DB >> 19427202

Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.

Bianca Sperl1, Markus H J Seifert, Thorsten Berg.   

Abstract

In this Letter, we report the natural products salvianolic acid A, salvianolic acid B, and caftaric acid as inhibitors of the protein-protein interactions mediated by the SH2 domains of the Src-family kinases Src and Lck, two established disease targets. Moreover, we propose a binding mode for the inhibitors based on molecular modeling, which will facilitate chemical optimization efforts of these important lead structures for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427202     DOI: 10.1016/j.bmcl.2009.04.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

Review 1.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

2.  Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.

Authors:  Chinmay Y Majmudar; Jonas W Højfeldt; Carl J Arevang; William C Pomerantz; Jessica K Gagnon; Pamela J Schultz; Laura C Cesa; Conor H Doss; Steven P Rowe; Victor Vásquez; Giselle Tamayo-Castillo; Tomasz Cierpicki; Charles L Brooks; David H Sherman; Anna K Mapp
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-08       Impact factor: 15.336

3.  Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer's disease.

Authors:  Ying Ying Cao; Ling Wang; Hu Ge; Xi Lin Lu; Zhong Pei; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2013-05-24       Impact factor: 2.943

Review 4.  Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.

Authors:  Sitanshu S Singh; Seetharama D Jois
Journal:  Adv Protein Chem Struct Biol       Date:  2017-10-06       Impact factor: 3.507

5.  Identification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancer.

Authors:  Ywh-Min Tzou; Sarah K Bailey; Kaiyu Yuan; Ronald Shin; Wei Zhang; Yabing Chen; Raj K Singh; Lalita A Shevde; N Rama Krishna
Journal:  Bioorg Med Chem Lett       Date:  2016-01-12       Impact factor: 2.823

Review 6.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

Review 7.  Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2011-05-11       Impact factor: 8.410

8.  Nanomolar inhibitors of the transcription factor STAT5b with high selectivity over STAT5a.

Authors:  Nagarajan Elumalai; Angela Berg; Kalaiselvi Natarajan; Andrej Scharow; Thorsten Berg
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-20       Impact factor: 15.336

9.  Salvianolic Acid B Ameliorates Lipopolysaccharide-Induced Albumin Leakage from Rat Mesenteric Venules through Src-Regulated Transcelluar Pathway and Paracellular Pathway.

Authors:  Chun-Shui Pan; Ying-Hua Liu; Yu-Ying Liu; Yu Zhang; Ke He; Xiao-Yuan Yang; Bai-He Hu; Xin Chang; Ming-Xia Wang; Xiao-Hong Wei; Jing-Yu Fan; Xin-Min Wu; Jing-Yan Han
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

Review 10.  Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.

Authors:  Malgorzata Szelag; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.